RARE logo

RARE

Ultragenyx Pharmaceutical Inc.

$33.59
+$2.41(+7.73%)
32
Overall
40
Value
25
Tech
--
Quality
Market Cap
$59.93M
Volume
1.68M
52W Range
$25.81 - $50.00
Target Price
$84.00

Latest News for RARE

Cantor Fitzgerald Reaffirms Their Buy Rating on Ultragenyx Pharmaceutical (RARE)
TipRanks Auto-Generated Intelligence Newsdesk2 days agoNov 21, 2025

Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on Ultragenyx Pharmaceutical yesterday and set a price target of $105.00. The comp......

Tactical Resources Corp. Proposes Business Combination to Form New Entity
TipRanks Canadian Auto-Generated Newsdesk4 days agoNov 19, 2025

Tactical Resources Corp. ( ($TSE:RARE) ) just unveiled an update. Tactical Resources Corp. announced that it has mailed meeting materials to its sh......

Tactical Resources Secures $140M Financing to Boost US Rare Earth Supply
TipRanks Canadian Auto-Generated Newsdesk13 days agoNov 10, 2025

An update from Tactical Resources Corp. ( ($TSE:RARE) ) is now available. Tactical Resources Corp has secured a US$140 million financing package fr......

RBC Capital Reaffirms Their Buy Rating on Ultragenyx Pharmaceutical (RARE)
TipRanks Auto-Generated Intelligence Newsdesk18 days agoNov 05, 2025

In a report released today, Luca Issi from RBC Capital maintained a Buy rating on Ultragenyx Pharmaceutical, with a price target of $72.00. Issi co......

TD Cowen Sticks to Their Buy Rating for Ultragenyx Pharmaceutical (RARE)
TipRanks Auto-Generated Intelligence Newsdesk19 days agoNov 05, 2025

In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Ultragenyx Pharmaceutical, with a price target of $75.00. The com......

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Exelixis (EXEL)
Brian Anderson24 days agoOct 30, 2025

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ultragenyx Pharmaceutical (RARE – Research Report) a......

Ultragenyx Begins Dosing in Aurora Study for Angelman Syndrome
TipRanks Auto-Generated Newsdesk24 days agoOct 30, 2025

Ultragenyx Pharmaceutical ( ($RARE) ) just unveiled an update. On October 30, 2025, Ultragenyx Pharmaceutical announced the dosing of the first pat......

Ultragenyx’s Ongoing Study on UX111: A Potential Game-Changer for MPS IIIA Treatment
TipRanks Clinical-Trials-Auto-Generated Newsdeska month agoOct 27, 2025

Ultragenyx Pharmaceutical, Inc. (($RARE)) announced an update on their ongoing clinical study. Ultragenyx Pharmaceutical Inc. is conducting a follo......

Ultragenyx’s LC-FAOD Study: A Strategic Move in Rare Disease Management
TipRanks Clinical-Trials-Auto-Generated Newsdeska month agoOct 27, 2025

Ultragenyx Pharmaceutical, Inc. (($RARE)) announced an update on their ongoing clinical study. Study Overview: Ultragenyx Pharmaceutical Inc. is co......

News data is sourced from MarketXLS API and updated regularly.
Showing 9 of 9 articles.

ABCD
1SymbolPriceChangeVol
2RARE$33.59+7.7%1.68M
3
4
5
6

Get Ultragenyx Pharmaceutical Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.